Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Myasthenia Gravis × inebilizumab × Clear all

Phase

Status

Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Myasthenia Gravis 1

Interventions

thymoglobulin 1 ravulizumab 1 prednylidene 1 inebilizumab 1 deltacortene 1 carmustine, poliferprosan 20 drug combination 1 Robotic Surgical Procedures 1 Rituximab 1 Prednisone 1 Peripheral Blood Stem Cell Transplantation 1 Melphalan 1 Etoposide 1 Cytarabine 1 Carmustine 1 Blood Specimen Collection 1 Antilymphocyte Serum 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04524273 2026-03-10

MINT

Amgen

Phase 3 Active not recruiting

238 enrolled 36 charts

Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡